1. Signaling Pathways
  2. Vitamin D Related/Nuclear Receptor
  3. Estrogen Receptor/ERR
  4. Estrogen Receptor/ERR Inhibitors

Estrogen Receptor/ERR Inhibitors

Estrogen receptor

ERα

ERβ

ERRα

ERRβ

ERRγ

Your Search Returned No Results.

Sorry. There is currently no product that acts on isoform together.

Please try each isoform separately.

Estrogen Receptor/ERR Inhibitors, Agonists, Antagonists, Activators, Modulators, Chemicals, Degraders & Ligands
Product Name Estrogen receptor ERα ERβ ERRα ERRβ ERRγ Purity
Tamoxifen
Estrogen receptor
          99.96%
4-Hydroxytamoxifen
Estrogen receptor, IC50: 3.3 nM
          99.96%
Kaempferol  
ERα
        99.92%
Tamoxifen Citrate
Estrogen receptor
          99.88%
(E/Z)-4-Hydroxytamoxifen
Estrogen receptor
          99.62%
Propyl pyrazole triol  
ERα
        99.11%
DPN    
ERβ, EC50: 0.85 nM
      99.66%
Giredestrant
ER
          98.98%
Raloxifene
Estrogen receptor
          99.62%
XCT790      
ERRα, IC50: 0.37 μM
    99.67%
(Z)-Ligustilide  
ERα
        99.11%
Saikosaponin D    
ERβ
      99.81%
SLU-PP-332      
ERRα, EC50: 98 nM
ERRβ, EC50: 230 nM
ERRγ, EC50: 430 nM
98.98%
Tamoxifen (Standard)
Estrogen receptor
         
MPP dihydrochloride  
ERα
ERβ
      99.54%
DY131        
ERRβ
ERRγ
99.72%
GSK5182          
ERRγ, IC50: 79 nM
99.10%
Palazestrant
17b-estradiol (E2), IC50: 6.4 nM
          99.93%
Endoxifen  
ERα
        99.51%
MPP hydrochloride  
ERα
ERβ
      99.28%
Smurf1-IN-A01  
ERα
        99.81%
Prinaberel  
hERα, IC50: 1200 nM
mouse ERα, IC50: 750 nM
rat ERα, IC50: 620 nM
hERβ, IC50: 5.4 nM
rat ERβ, IC50: 3.1 nM
mouse ERβ, IC50: 3.7 nM
      98.05%
ERRα antagonist-1      
ERRα
    99.71%
Kaempferol (Standard)  
ERα
       
Brilanestrant  
ERα, IC50: 0.7 nM
        99.85%
Amcenestrant  
ERα, EC50: 0.2 nM
        99.79%
DS45500853      
ERRα
    99.18%
Erteberel    
ERβ, Ki: 1.54 nM
ERβ, EC50: 3.61 nM
      99.88%
Hexestrol  
ERα, Ki: 0.06 nM
ERβ, Ki: 0.06 nM
      99.79%
(-)-(E)-Guggulsterone  
ERα
        99.19%
(E)-4-Hydroxytamoxifen
Estrogen receptor
          98.27%
PROTAC ERRα Degrader-3      
ERRα
    98.82%
WAY-200070  
ERα, IC50: 155 nM
ERβ, IC50: 2.3 nM
      99.57%
FLTX1  
ERα, IC50: 87.5 nM
        99.75%
ERRγ agonist-1          
ERRγ
98.02%
DS20362725      
ERRα
    99.34%
GNE-149  
ERα, IC50: 0.053 nM
        99.18%
Regaloside C
Estrogen receptor
          99.62%
Benzophenone-2  
ERα
        99.66%
PROTAC ERα Degrader-2  
ERα
        98.92%
H3B-5942  
ERαY537S, Ki: 0.41 nM
ERαWT, Ki: 1 nM
        98.25%
PROTAC ERα Degrader-4  
ERα, Ki: 5.08 μM
ERβ, Ki: 26.20 μM
      99.06%
2-Hydroxyestrone
Estrogen receptor
          98.57%
Estrogen receptor-agonist-1  
ERα
        99.62%
Ferutinin  
ERα, IC50: 33.1 nM
ERβ, IC50: 180.5 nM
      99.23%
PROTAC ERRα ligand 1      
ERRα, IC50: 0.04 μM
    98.61%
Tamoxifen-d5
Estrogen receptor
          99.99%
PROTAC ER Degrader-4
ER
          98.78%
(±)-8-Prenylnaringenin  
ERα, IC50: 57 nM
ERβ, IC50: 68 nM
      99.97%
Hydroxytyrosol acetate    
ERβ
      98.10%
PHTPP-1304    
ERβ, DC50: 2 nM
      99.96%
SR19881        
ERRβ, EC50: 0.63 μM
ERRγ, EC50: 0.39 μM
99.30%
PROTAC ERRα Degrader-1      
ERRα
    98.22%
Y134  
ERα, Ki: 0.09 nM
ERβ, Ki: 11.31 nM
      99.67%
GTX-758  
ERα
        99.59%
Estrogen receptor β antagonist 2  
ERα, IC50: 109.10 μM
ERβ, IC50: 0.63 μM
      98.39%
Acolbifene  
ERα, IC50: 2 nM (E2-induced transcriptional activity)
ERβ, IC50: 0.4 nM (E2-induced transcriptional activity)
      99.42%
PROTAC ERα Degrader-6  
ERα, DC50: 0.12 μM
       
2-Ethylhexyl diphenyl phosphate          
ERRγ, IC50: 1.3 μM
AC-186  
ERα, EC50: 5000 nM
ERβ, EC50: 6 nM
      99.61%
ERRα antagonist-2      
ERRα, IC50: 0.80 μM
    99.07%
Estrogen receptor-IN-1  
ERα, IC50: 13 μM
ERβ, IC50: 5 μM
      99.87%
ERα degrader-2  
ERα, IC50: 4.6 nM
        98.30%
OP-1074  
ERα
ERβ
      99.77%
ERα antagonist 1  
ERα
       
CARM1-IN-6  
ERα
        99.59%
PROTAC AR Degrader-12  
ERα
       
(R,R)-THC  
ERα, Ki: 9.0 nM
ERβ, Ki: 3.6 nM
      99.0%
LY117018
Estrogen receptor
          99.47%
Acolbifene hydrochloride  
ERα, IC50: 2 nM (E2-induced transcriptional activity)
ERβ, IC50: 0.4 nM (E2-induced transcriptional activity)
      99.00%
Bisphenol C  
ERα
        ≥98.0%
Giredestrant tartrate
Estrogen receptor
         
PVTX-321  
ERα
       
Anticancer agent 276  
ERα
       
ERα degrader 5  
ERα, EC50: 1.1 nM
ERα, IC50: 0.9 nM
ERβ, IC50: 2.3 nM
     
OP-1690  
ERα, pIC50: 7.5
       
THIQ 40  
ERα
       
PROTAC ERα Degrader-13  
ERα
       
Trioxifene mesylate  
hERα, IC50: 203.49 nM
hERα, Ki: 20.84 nM
hERβ, IC50: 1506.04 nM
hERβ, Ki: 144.85 nM
     
WAY-166818    
ERβ
     
4',2-Dihydroxy-4,6-dimethoxydihydrochalcone
Estrogen receptor
          98.0%
ERα degrader 11  
ERα
       
F0840-0093  
ERα
       
FERb 033  
ERα, EC50: 19 nM
ERβ, EC50: 4.8 nM
ERβ, Ki: 7.1 nM
     
ERα degrader 9  
ERα
       
Artonin U  
hERα
       
GNE-5472  
ERα
       
AZD9496-O-C3-O-C3-O-C-acid  
ERα
       
PROTAC ERα Degrader-12  
ERα
       
Estrogen receptor antagonist 8
Estrogen receptor
         
ERα antagonist 2  
ERα, IC50: 1729 nM
       
X15695  
ERα
        98.45%
ER degrader 12  
ERα, IC50: 2.3 nM
ERβ, IC50: 80.2 nM
     
PROTAC ER Degrader-16  
ERα, DC50: 1.4 nM
ERα, IC50: 1.9 nM
       
Trioxifene  
hERα, IC50: 203.49 nM
hERα, Ki: 20.84 nM
hERβ, IC50: 1506.04 nM
hERβ, Ki: 144.85 nM
     
ER ligand-15  
ERα
       
PROTAC ERα Degrader-9  
ERα, Ki: 0.25 μM
ERβ, Ki: >79 μM
     
HMR-3339
Estrogen receptor
         
CHF 4227 free base  
hERα, Ki: 0.017 nM
hERβ, Ki: 0.099 nM
     
CMP8  
MGERα, IC50: 29 nM
MGRERα, IC50: 41 nM
hERα, IC50: 1100 nM
hERβ, IC50: 2200 nM
     
CDD-1274  
ERαY537S
ERα
       
PROTAC ERα Degrader-7  
ERα, DC50: 0.000006 μM
       
NEP168  
ERα
       
LX-039
Estrogen receptor, EC50: 2.29 nM
         
ERα ligand 4  
ERα
       
rel-Erteberel    
ERβ, IC50: 1.54 nM
ERβ, EC50: 3.61 nM
      99.63%
ERRγ-IN-1  
ERα, IC50: 1.24 μM
   
ERRβ, IC50: 1.33 μM
ERRγ, IC50: 0.04 μM
ER degrader 6  
ERα
       
ERβ agonist-2    
ERβ, EC50: 800 or low nM
     
ERB-2    
ERβ
     
(+)-Medicarpin    
ERβ
     
ERRγ inverse agonist 2          
ERRγ, Kd: 6.5 μM
ERα degrader 10  
ERα, IC50: 24 nM
       
HIT-2  
ERα
       
Benoxacor      
ERRα
    99.39%
7β-Hydroxy-epi-androsterone    
ERβ
     
ERβ agonist-1    
ERβ, EC50: 46.8 nM
     
SNG-8023  
ERα
       
ent-Estradiol  
hERα, IC50: 151 nM
mouse ERα, IC50: 268 nM
rat ERα, IC50: 246 nM
hERβ, IC50: 24.9 nM
rat ERβ, IC50: 9.59 nM
mouse ERβ, IC50: 8.17 nM
     
FRAGHIT-4  
ERα
       
(1S,3R)-GNE-502  
ERα, EC50: 13 nM
       
KAT6-IN-4  
ERα
       
CS-1-103
ER, EC50: 0.36 μM
         
BY13  
ERα
       
PSDalpha  
ERα
       
His-TERRα      
ERRα
   
ERα ligand 3  
ERα
       
ERα degrader 14  
ERα
       
Estrogen receptor modulator 6  
ERα, Ki: 8.4 nM
ERβ, Ki: 0.44 nM
     
PROTAC ERα Degrader-11  
ERα
ERβ
     
Tamoxifen-PEG-Clozapine  
ERα
       
PROTAC ER Degrader-11
ER
         
(R)-DPN  
ERα, EC50: 2.9 nM
ERβ, EC50: 0.8 nM
     
ERRγ inverse agonist 1  
ERα, IC50: 1.240 μM
   
ERRβ, IC50: 1.330 μM
ERRγ, IC50: 0.040 μM
LSD1/ER-IN-1  
ERα
ERβ
     
4,4'-(Cyclohexylidenemethylene)diphenol  
ERα
ERβ
     
Isopaucifloral F    
ERβ, EC50: 46.96 μM
     
ERα/ERβ antagonist-1  
ERα
ERβ